Preclinical Evaluation of [18F]THK-5105 Enantiomers: Effects of Chirality on Its Effectiveness as a Tau Imaging Radiotracer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical Evaluation of [18F]THK-5105 Enantiomers: Effects of Chirality on Its Effectiveness as a Tau Imaging Radiotracer
Authors
Keywords
Alzheimer’s disease, Positron emission tomography, Tau proteins, Stereoisomerism
Journal
MOLECULAR IMAGING AND BIOLOGY
Volume 18, Issue 2, Pages 258-266
Publisher
Springer Nature
Online
2015-07-20
DOI
10.1007/s11307-015-0879-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using 18F-THK5105 PET
- (2014) Nobuyuki Okamura et al. BRAIN
- Enantioselective Radiosynthesis of Positron Emission Tomography (PET) Tracers Containing [18F]Fluorohydrins
- (2014) Thomas J. A. Graham et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Mechanistic Basis of Phenothiazine-Driven Inhibition of Tau Aggregation
- (2013) Elias Akoury et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer’s disease patients
- (2013) Anton Forsberg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Synthesis and preliminary evaluation of 2-arylhydroxyquinoline derivatives for tau imaging
- (2013) Tetsuro Tago et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease
- (2013) Bruno Bulic et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease
- (2013) N. Okamura et al. JOURNAL OF NUCLEAR MEDICINE
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
- (2013) Masahiro Maruyama et al. NEURON
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer’s disease pathology
- (2012) Ryuichi Harada et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease
- (2012) Marie M. Svedberg et al. NUCLEAR MEDICINE AND BIOLOGY
- Association Between In Vivo Fluorine 18–Labeled Flutemetamol Amyloid Positron Emission Tomography Imaging and In Vivo Cerebral Cortical Histopathology
- (2011) David A. Wolk ARCHIVES OF NEUROLOGY
- 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
- (2011) M. T. Fodero-Tavoletti et al. BRAIN
- Use of Florbetapir-PET for Imaging β-Amyloid Pathology
- (2011) Christopher M. Clark JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
- (2009) Diane P. Hanger et al. TRENDS IN MOLECULAR MEDICINE
- Performance evaluation of a high-sensitivity large-aperture small-animal PET scanner: ClairvivoPET
- (2008) Tetsuro Mizuta et al. ANNALS OF NUCLEAR MEDICINE
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
- (2008) Milos D. Ikonomovic et al. BRAIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started